Table 2 Statistical analysis of the primary and secondary outcomes of the study
ESPB | Control | p-value | missing | ||
|---|---|---|---|---|---|
PCA total consumption: primary outcome (mg) | Median (25–75 IQR) | 8.5 (5.5) | 20 (14) | < 0.0001 | - |
Intraoperative fentanyl use (mcg) | 0.021 | - | |||
Median (IQR) | 200 (150) | 250 (295) | - | ||
Intraoperative blood loss (mL) | 0.870 | - | |||
Median (IQR) | 250 (100) | 250 (337.5) | - | ||
NRS at 2 h | < 0.001 | - | |||
Median (IQR) | 0 (1.75) | 5 (2.75) | - | ||
NRS at 6 h | < 0.001 | - | |||
Median (IQR) | 2 (1.75) | 5 (2.75) | - | ||
NRS at 12 h | 0.002 | - | |||
Median (IQR) | 3 (1) | 5 (1.75) | - | ||
NRS at 24 h | 0.004 | - | |||
Median (IQR) | 3 (2) | 5 (2) | - | ||
NRS at 36 h | 0.002 | - | |||
Median (IQR) | 2 (1.75) | 4 (1.75) | - | ||
NRS at 48 h | 0.527 | 19 | |||
Median (IQR) | 2 (1.5) | 3 (1.63) | 19 | ||
PCA 0–2 h (mg) | 0.007 | - | |||
Median (IQR) | 0 (0) | 2 (3) | - | ||
PCA 2–6 h (mg) | < 0.0001 | - | |||
Median (IQR) | 1 (1.75) | 3 (1.75) | - | ||
PCA 6–12 h (mg) | 0.002 | - | |||
Median (IQR) | 2 (1) | 3 (1.75) | - | ||
PCA 12–24 h (mg) | 0.002 | - | |||
Median (IQR) | 2 (2.75) | 5 (3.5) | - | ||
PCA 24–36 h (mg) | 0.005 | - | |||
Median (IQR) | 3 (2.75) | 5 (4.75) | - | ||
PCA 36–48 h (mg) | 0.046 | 13 | |||
Median (IQR) | 4.5 (3.30) | 3.5 (4) | 13 | ||
LOS (days) | Median (IQR) | 5 (4) | 7 (7) | 0.226 | - |
Patients’ satisfaction | < 0.0001 | - | |||
Median (IQR) | 8 (2.75) | 6 (1) | - |